Agomab
Biotechnology Research
Antwerp, Be
68 employees
- Employees
- 68
- Contacts
- 3
- Emails
- 3
- Phones
- 1
Agomab Overview
- Headquarters
- Antwerp, Be
- Website
- agomab.com
- Industry
- Biotechnology Research
- Employees
- 68
- Founded
- 2017
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Agomab
Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases.
Agomab Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Agomab Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Ming Fang | Redmile Group |
View
|
|
| Natalie De Jonge | Aalst, Flemish Region, Belgium |
Email
|
|
| Henk D. | Digital Leadership in Pharma, Biotech | Ghent, Flemish Region, Belgium |
Email
Phone
|
| Philippe Wiesel | Chief Medical Officer at Agomab | Arlington, Massachusetts, United States |
Email
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Compare Similar Companies to Agomab
Argenx
Biotechnology Research
Galapagos
Biotechnology Research
Ablynx
Biotechnology Research
Etherna
Biotechnology
Aphea.Bio
Biotechnology Research
Confo Therapeutics
Biotechnology
Biotalys
Biotechnology Research
PANTERA
Pharmaceutical Manufacturing
Flamingo Therapeutics
Biotechnology Research
ExeVir
Biotechnology